Activation of complement mediates antiphospholipid antibody-induced pregnancy loss

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Lupus

• Publication date

  2003-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1191/0961203303lu397oaPMID 12892394
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal Loss

  2002cited by this paper
• A critical role for murine complement regulator crry in fetomaternal tolerance.

  2000cited by this paper
• Therapeutic Interventions in the Complement System

  2000cited by this paper
• Complement as a Regulatory and Effector Pathway in Human Diseases

  2000cited by this paper

• The complement system in human pregnancy and preeclampsia

  2025cites this paper
• Increased risk of antiphospholipid syndrome in patients with psoriasis: a retrospective cohort study

  2025cites this paper
• Mechanism of antiphospholipid antibody-mediated thrombosis in antiphospholipid syndrome

  2025cites this paper
• Guidelines on the investigation and management of antiphospholipid syndrome

  2024cites this paper
• Pregnancy in antiphospholipid syndrome: what should a rheumatologist know?

  2024cites this paper
• The Role of Immunotherapy in the Treatment of Recurrent Miscarriage

  2023cites this paper
• Evolution of Antiphospholipid Syndrome

  2023cites this paper
• Animal Models of Cardiovascular Complications of Pregnancy

  2022cites this paper
• Crosstalk between inflammation and coagulation: Focus on pregnancy related complications

  2021cites this paper
• Antiphospholipid-Syndrom bei Kindern und Jugendlichen

  2021cites this paper
• Early-onset preeclampsia - The impact of antiphospholipid antibodies on disease severity.

  2021cites this paper
• The clinical and serological associations of hypocomplementemia in a longitudinal sle cohort.

  2020cites this paper
• Antiphospholipid autoantibody detection is important in all patients with systemic autoimmune diseases.

  2020cites this paper
• Recurrent pregnancy loss

  2020cites this paper
• Pathogenic roles of anti-C1q antibodies in recurrent pregnancy loss.

  2019cites this paper
• News and meta-analysis regarding anti-Beta 2 glycoprotein I antibodies and their determination.

  2019cites this paper
• Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: Case series and review of literature.

  2019cites this paper
• Immunotherapy for recurrent pregnancy loss.

  2019cites this paper
• Comparison of therapeutic interventions for recurrent pregnancy loss in association with antiphospholipid syndrome: A systematic review and network meta‐analysis

  2019cites this paper
• Thrombocytopenia in pregnancy: Diagnosis and approach to management.

  2019cites this paper
• The Complement System

  2019cites this paper
• Antiphospholipid antibodies in women with severe preeclampsia and placental insufficiency: a case-control study

  2018cites this paper
• Antiphospholipid Antibodies in Lupus: An Update

  2018cites this paper
• Management of Systemic Lupus Erythematosus During Pregnancy.

  2017cites this paper
• Complement activation fragment C 3 a is a sensitive biomarker for patients with recurrent miscarriage

  2017cites this paper
• Clinical Risk Assessment in the Antiphospholipid Syndrome: Current Landscape and Emerging Biomarkers

  2017cites this paper
• Pathogenesis and management of antiphospholipid syndrome

  2017cites this paper
• Antibodies Against Complement Components: Relevance for the Antiphospholipid Syndrome—Biomarkers of the Disease and Biopharmaceuticals

  2017cites this paper
• Chapter 39 – Pregnancy and Rheumatic Diseases

  2017cites this paper
• Serum Protein Profile in Women With Pregnancy Morbidity Associated With Antiphospholipid Syndrome

  2017cites this paper
• Diagnosis and management of the antiphospholipid syndrome.

  2017cites this paper
• Reproductive Issues in Women with Bleeding and Thrombotic Disorders

  2016cites this paper
• Catastrophic Antiphospholipid Syndrome

  2016cites this paper
• Randomized controlled study of pre‐conception thromboprophylaxis among patients with recurrent spontaneous abortion related to antiphospholipid syndrome

  2016cites this paper
• Aberrant maternal inflammation as a cause of pregnancy complications: A potential therapeutic target?

  2015cites this paper
• Complement-Targeted Therapies in Lupus

  2015cites this paper
• Obstetrical Considerations and Management of Antiphospholipid Syndrome

  2015cites this paper
• THE ROLE OF ABNORMAL MATERNAL INFLAMMATION IN THE PATHOGENESIS OF PREGNANCY COMPLICATIONS

  2014cites this paper
• Pre-eclampsia as a manifestation of antiphospholipid syndrome: assessing the current status

  2014cites this paper
• Antithrombotic treatment for pregnancy complications: which path for the journey to precision medicine?

  2014cites this paper
• Recent advances in the antiphospholipid antibody syndrome

  2014cites this paper
• C URRENT OPINION Recent advances in the antiphospholipid antibody syndrome

  2014cites this paper
• Immunologic Changes During Pregnancy

  2014cites this paper
• Pregnancy in rheumatic disease patients.

  2013cites this paper
• This information is current as 2/Complement Receptor 1-Deficient Mice Injury in Complement Receptor Mesenteric Ischemia/Reperfusion-Induced Anti-Phospholipid Antibodies Restore

  2013cites this paper
• The use of eculizumab in renal transplantation

  2013cites this paper
• Diffuse Alveolar Hemorrhage and Libman-Sacks Endocarditis as a Manifestation of Possible Primary Antiphospholipid Syndrome

  2013cites this paper
• Pregnancy and Thrombophilia

  2013cites this paper
• Recurrent Miscarriage including Cervical Incompetence

  2012cites this paper
• Unilateral uterine ischemia/reperfusion-induced bilateral fetal loss and fetal growth restriction in a murine model require intact complement component 5.

  2012influential citation
• Maternal Diseases Complicating Pregnancy: Diabetes, Tumors, Preeclampsia, Lupus Anticoagulant

  2012cites this paper
• The Investigation and Treatment of Couples with Recurrent First- trimester and Second-trimester Miscarriage

  2011cites this paper
• Early Pregnancy

  2011influential citation
• Heparin Treatment in Antiphospholipid Syndrome With Recurrent Pregnancy Loss: A Systematic Review and Meta-Analysis

  2010cites this paper
• Anetodermic Primary Cutaneous B-Cell Lymphoma

  2010cites this paper
• Catastrophic antiphospholipid syndrome

  2010cites this paper
• Anetodermic primary cutaneous B-cell lymphoma: a unique clinicopathological presentation of lymphoma possibly associated with antiphospholipid antibodies.

  2010cites this paper
• Effects of Polyclonal IgG Derived from Patients with Different Clinical Types of the Antiphospholipid Syndrome on Monocyte Signaling Pathways

  2010cites this paper
• This information is current as Signaling Pathways Antiphospholipid Syndrome on Monocyte Patients with Different Clinical Types of the Effects of Polyclonal IgG Derived from Anisur

  2010cites this paper
• Microangiopathic antiphospholipid antibody-associated syndromes: a tribute to Ronald Asherson.

  2008cites this paper
• The primary, secondary, catastrophic, and seronegative variants of the antiphospholipid syndrome: a personal history long in the making.

  2008cites this paper
• The catastrophic antiphospholipid (Asherson's) syndrome.

  2008cites this paper
• The Primary, Secondary, Catastrophic, and Seronegative Variants of the Antiphospholipid Syndrome: A Personal History Long in the Making

  2008cites this paper
• Role of complement in antiphospholipid antibody-mediated thrombosis

  2007cites this paper
• Catastrophic Antiphospholipid Syndrome: Lessons from the “CAPS Registry”

  2007cites this paper
• Collagen Vascular Diseases

  2007cites this paper
• Dermatomiositis y sistema del complemento: Relación entre actividad de la enfermedad y grado de activación del complemento. Comparación con marcadores bioquímicos tradicionales

  2007cites this paper
• Reduced placental growth and hCG secretion in vitro induced by antiphospholipid antibodies but not by anti-Ro or anti-La: studies on sera from women with SLE/PAPS

  2007cites this paper
• Catastrophic antiphospholipid syndrome: therapeutic developments

  2007cites this paper
• Primary Anetoderma and Antiphospholipid Antibodies—Review of the Literature

  2007cites this paper
• Microangiopathic antiphospholipid-associated syndromes revisited new concepts relating to antiphospholipid antibodies and syndromes.

  2007cites this paper
• Perinatal Implications of the Antiphospholipid Syndrome

  2007cites this paper
• The antiphospholipid antibody syndrome: diagnosis, skin manifestations and current therapy.

  2006cites this paper
• Catastrophic antiphospholipid (Asherson's) syndrome.

  2006cites this paper
• [New insights into the pathogenicity of antiphospholipid antibodies].

  2006cites this paper
• Thrombotic microangiopathic antiphospholipid syndromes: a continuum of conditions?

  2006cites this paper
• Catastrophic antiphospholipid syndrome.

  2006cites this paper
• Obstetrical Antiphospholipid Syndrome

  2006cites this paper
• The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial.

  2006cites this paper
• Antiphospholipid Syndrome — Experimental Models: Insight into Etiology, Pathogenesis, and Treatments

  2006cites this paper
• 16 Catastrophic Antiphospholipid Syndrome

  2006cites this paper
• Impaired factor XIIa-dependent activation of fibrinolysis in treated antiphospholipid syndrome gestations developing late-pregnancy complications.

  2006cites this paper
• Intravenous immunoglobulin and recurrent pregnancy loss

  2005cites this paper
• Antiphospholipid antibodies as a cause of pulmonary capillaritis and diffuse alveolar hemorrhage: a case series and literature review.

  2005cites this paper
• Anticuerpos antifosfolipidos y anticuerpos antinucleares en pacientes con pérdidas de embarazo y pacientes con infertilidad primaria

  2005cites this paper
• Diffuse alveolar hemorrhage: a nonthrombotic antiphospholipid lung syndrome?

  2005cites this paper
• Unexplained intrauterine fetal death is accompanied by activation of complement

  2005cites this paper
• Editorial Diffuse Alveolar Hemorrhage: A Nonthrombotic Antiphospholipid Lung Syndrome?

  2005cites this paper
• Injury in Autoimmunity-Prone Mice Accelerated Ischemia / Reperfusion-Induced

  2004cites this paper
• Geburtshilfliches Management bei Patientinnen mit primärem Antiphospholipid-Syndrom (APS) - Literaturübersicht und Fallbeispiel

  2004cites this paper
• Anti-Phospholipid Antibodies Restore Mesenteric Ischemia/Reperfusion-Induced Injury in Complement Receptor 2/Complement Receptor 1-Deficient Mice1

  2004cites this paper
• Unexplained intrauterine fetal death is accompanied by activation of complement.

  2004cites this paper
• 2 / Complement Receptor 1-Deficient Mice Injury in Complement Receptor Mesenteric Ischemia / Reperfusion-Induced AntiPhospholipid Antibodies

  2004cites this paper
• Accelerated Ischemia/Reperfusion-Induced Injury in Autoimmunity-Prone Mice12

  2004cites this paper
• Aberrant maternal in fl ammation as a cause of pregnancy complications: A potential therapeutic target?

  year unknowncites this paper